Schizophrenia Research and Treatment (Jan 2016)

Neuroactive Steroids in First-Episode Psychosis: A Role for Progesterone?

  • Martino Belvederi Murri,
  • Flaminia Fanelli,
  • Uberto Pagotto,
  • Elena Bonora,
  • Federico Triolo,
  • Luigi Chiri,
  • Fabio Allegri,
  • Marco Mezzullo,
  • Marco Menchetti,
  • Valeria Mondelli,
  • Carmine Pariante,
  • Domenico Berardi,
  • Ilaria Tarricone

DOI
https://doi.org/10.1155/2016/1942828
Journal volume & issue
Vol. 2016

Abstract

Read online

Neuroactive steroids may play a role in the pathophysiology of psychotic disorders, but few studies examined this issue. We compared serum levels of cortisol, testosterone, dehydroepiandrosterone, and progesterone between a representative sample of first-episode psychosis (FEP) patients and age- and gender-matched healthy subjects. Furthermore, we analyzed the associations between neuroactive steroids levels and the severity of psychotic symptom dimensions. Male patients had lower levels of progesterone than controls (p=0.03). Progesterone levels were inversely associated with the severity of positive symptoms (p=0.007). Consistent with preclinical findings, results suggest that progesterone might have a role in the pathophysiology of psychotic disorders.